{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:59:00Z","timestamp":1790636340219,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04483-4","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:06:28Z","timestamp":1783332388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum 25(OH)D and HDL-C as site-specific metabolic markers of cervical lymph node metastasis in papillary thyroid carcinoma"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5432-7171","authenticated-orcid":false,"given":"Shanyu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-5253","authenticated-orcid":false,"given":"Nannan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-6472","authenticated-orcid":false,"given":"Guo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6027-0029","authenticated-orcid":false,"given":"Jianjian","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3121-3365","authenticated-orcid":false,"given":"Danlei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7672-8394","authenticated-orcid":false,"given":"Tian\u2019an","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7024-0795","authenticated-orcid":false,"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"4483_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"4483_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41574-019-0263-x","volume":"16","author":"J Kim","year":"2020","unstructured":"Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16:17\u201329. https:\/\/doi.org\/10.1038\/s41574-019-0263-x.","journal-title":"Nat Rev Endocrinol"},{"key":"4483_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/jnci\/djp354","volume":"101","author":"G Pellegriti","year":"2009","unstructured":"Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst. 2009;101:1575\u201383. https:\/\/doi.org\/10.1093\/jnci\/djp354.","journal-title":"J Natl Cancer Inst"},{"key":"4483_CR4","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1002\/cam4.3970","volume":"10","author":"M Zhai","year":"2021","unstructured":"Zhai M, Zhang D, Long J, Gong Y, Ye F, Liu S, et al. The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study. Cancer Med. 2021;10:4542\u201354. https:\/\/doi.org\/10.1002\/cam4.3970.","journal-title":"Cancer Med"},{"key":"4483_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","volume":"68","author":"J Wang","year":"2020","unstructured":"Wang J, Yu F, Shang Y, Ping Z, Liu L. Thyroid cancer: incidence and mortality trends in China, 2005\u20132015. Endocrine. 2020;68:163\u201373. https:\/\/doi.org\/10.1007\/s12020-020-02207-6.","journal-title":"Endocrine"},{"key":"4483_CR6","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S1470-2045(16)30166-8","volume":"17","author":"MS Brose","year":"2016","unstructured":"Brose MS, Cabanillas ME, Cohen EE, et al. Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016;17:1272\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(16)30166-8.","journal-title":"Lancet Oncol"},{"key":"4483_CR7","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/JCO.2014.59.8391","volume":"33","author":"MA Adam","year":"2015","unstructured":"Adam MA, Pura J, Goffredo P, et al. Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol. 2015;33:2370\u20135. https:\/\/doi.org\/10.1200\/JCO.2014.59.8391.","journal-title":"J Clin Oncol"},{"key":"4483_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/archoto.2010.112","volume":"136","author":"KD Salter","year":"2010","unstructured":"Salter KD, Andersen PE, Cohen JI, et al. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality. Arch Otolaryngol Head Neck Surg. 2010;136:692\u20136. https:\/\/doi.org\/10.1001\/archoto.2010.112.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"4483_CR9","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1245\/s10434-011-2129-x","volume":"19","author":"HS Kazaure","year":"2012","unstructured":"Kazaure HS, Roman SA, Sosa JA. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. Ann Surg Oncol. 2012;19:1874\u201380. https:\/\/doi.org\/10.1245\/s10434-011-2129-x.","journal-title":"Ann Surg Oncol"},{"key":"4483_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.4158\/EP14466.DSCR","volume":"21","author":"L Davies","year":"2015","unstructured":"Davies L, Morris LG, Haymart M, et al. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract. 2015;21:686\u201396. https:\/\/doi.org\/10.4158\/EP14466.DSCR.","journal-title":"Endocr Pract"},{"key":"4483_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12:646\u201353. https:\/\/doi.org\/10.1038\/nrendo.2016.110.","journal-title":"Nat Rev Endocrinol"},{"key":"4483_CR12","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1200\/JCO.2016.67.6437","volume":"34","author":"TJ Robinson","year":"2016","unstructured":"Robinson TJ, Thomas S, Dinan MA, et al. How many lymph nodes are enough? Assessing the adequacy of lymph node yield for papillary thyroid cancer. J Clin Oncol. 2016;34:3434\u20139. https:\/\/doi.org\/10.1200\/JCO.2016.67.6437.","journal-title":"J Clin Oncol"},{"key":"4483_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.anl.2025.01.008","volume":"52","author":"M Nakamura","year":"2025","unstructured":"Nakamura M, Monden N, Terada T, et al. Risk factors for distant metastasis in papillary thyroid carcinoma: Association with lateral lymph node metastasis. Auris Nasus Larynx. 2025;52:174\u20138. https:\/\/doi.org\/10.1016\/j.anl.2025.01.008.","journal-title":"Auris Nasus Larynx"},{"key":"4483_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/biomedicines10010179","volume":"10","author":"YJ Ryu","year":"2022","unstructured":"Ryu YJ, Kwon SY, Lim SY, et al. Predictive factors for skip lymph node metastasis and their implication on recurrence in papillary thyroid carcinoma. Biomedicines. 2022;10:179. https:\/\/doi.org\/10.3390\/biomedicines10010179.","journal-title":"Biomedicines"},{"key":"4483_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12022-014-9327-6","volume":"25","author":"DY Shin","year":"2014","unstructured":"Shin DY, Lee YK, Kim KJ, et al. Thyroid cancers with benign-looking sonographic features have different lymph node metastatic risk and histologic subtypes according to nodule size. Endocr Pathol. 2014;25:378\u201384. https:\/\/doi.org\/10.1007\/s12022-014-9327-6.","journal-title":"Endocr Pathol"},{"key":"4483_CR16","doi-asserted-by":"publisher","first-page":"102007","DOI":"10.1016\/j.eclinm.2023.102007","volume":"60","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lai F, Lin B, et al. Deep learning to predict cervical lymph node metastasis from intraoperative frozen section of tumour in papillary thyroid carcinoma: a multicentre diagnostic study. EClinicalMedicine. 2023;60:102007. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102007.","journal-title":"EClinicalMedicine"},{"key":"4483_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s12885-023-11721-5","volume":"23","author":"B Wei","year":"2023","unstructured":"Wei B, Yao J, Peng C, et al. Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma. BMC Cancer. 2023;23:1225. https:\/\/doi.org\/10.1186\/s12885-023-11721-5.","journal-title":"BMC Cancer"},{"key":"4483_CR18","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3390\/biomedicines10102575","volume":"10","author":"PP Issa","year":"2022","unstructured":"Issa PP, Mueller L, Hussein M, et al. Radiologist versus non-radiologist detection of lymph node metastasis in papillary thyroid carcinoma by ultrasound: A meta-analysis. Biomedicines. 2022;10:2575. https:\/\/doi.org\/10.3390\/biomedicines10102575.","journal-title":"Biomedicines"},{"key":"4483_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3892\/etm.2024.12437","volume":"27","author":"Q Liu","year":"2024","unstructured":"Liu Q, Jiang X, Tu W, et al. Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review). Exp Ther Med. 2024;27:149. https:\/\/doi.org\/10.3892\/etm.2024.12437.","journal-title":"Exp Ther Med"},{"key":"4483_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid. 2025;35:841\u2013985. https:\/\/doi.org\/10.1177\/10507256251363120.","journal-title":"Thyroid"},{"key":"4483_CR21","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:1856\u201383. https:\/\/doi.org\/10.1093\/annonc\/mdz400.","journal-title":"Ann Oncol"},{"key":"4483_CR22","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13:1774\u2013808. https:\/\/doi.org\/10.7150\/thno.82920.","journal-title":"Theranostics"},{"key":"4483_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","volume":"10","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu S. High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks. Cell Death Discov. 2024;10:378. https:\/\/doi.org\/10.1038\/s41420-024-02157-2.","journal-title":"Cell Death Discov"},{"key":"4483_CR24","doi-asserted-by":"publisher","first-page":"e202302285","DOI":"10.26508\/lsa.202302285","volume":"7","author":"B Fu","year":"2023","unstructured":"Fu B, Lou Y, Lu X, et al. tRF-1:30-Gly-CCC-3 inhibits thyroid cancer via binding to PC and modulating metabolic reprogramming. Life Sci Alliance. 2023;7:e202302285. https:\/\/doi.org\/10.26508\/lsa.202302285.","journal-title":"Life Sci Alliance"},{"key":"4483_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40001-022-00964-w","volume":"28","author":"W Goto","year":"2023","unstructured":"Goto W, Kashiwagi S, Takada K, et al. Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy. Eur J Med Res. 2023;28:2. https:\/\/doi.org\/10.1186\/s40001-022-00964-w.","journal-title":"Eur J Med Res"},{"key":"4483_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2023.05.002","volume":"93","author":"M Lee-Rueckert","year":"2023","unstructured":"Lee-Rueckert M, Canyelles M, Tondo M, et al. Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism. Semin Cancer Biol. 2023;93:36\u201351. https:\/\/doi.org\/10.1016\/j.semcancer.2023.05.002.","journal-title":"Semin Cancer Biol"},{"key":"4483_CR27","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1111\/bph.15424","volume":"179","author":"MP Sheeley","year":"2022","unstructured":"Sheeley MP, Andolino C, Kiesel VA, Teegarden D. Vitamin D regulation of energy metabolism in cancer. Br J Pharmacol. 2022;179:2890\u2013905. https:\/\/doi.org\/10.1111\/bph.15424.","journal-title":"Br J Pharmacol"},{"key":"4483_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.apsb.2018.09.002","volume":"9","author":"X Wu","year":"2019","unstructured":"Wu X, Hu W, Lu L, et al. Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment. Acta Pharm Sin B. 2019;9:203\u201319. https:\/\/doi.org\/10.1016\/j.apsb.2018.09.002.","journal-title":"Acta Pharm Sin B"},{"key":"4483_CR29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12020-025-04194-y","volume":"88","author":"X Chen","year":"2025","unstructured":"Chen X, Wang HY, Yu L, et al. Correlation of multiple peripheral blood parameters with metastasis and invasion of papillary thyroid cancer: a retrospective cohort study. Endocrine. 2025;88:757\u201365. https:\/\/doi.org\/10.1007\/s12020-025-04194-y.","journal-title":"Endocrine"},{"key":"4483_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1186\/s12885-025-14373-9","volume":"25","author":"ZK Ning","year":"2025","unstructured":"Ning ZK, Yi H, Yang T, et al. Single-cell perspective on the monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer. BMC Cancer. 2025;25:1203. https:\/\/doi.org\/10.1186\/s12885-025-14373-9.","journal-title":"BMC Cancer"},{"key":"4483_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s40618-014-0165-7","volume":"38","author":"B Balla","year":"2015","unstructured":"Balla B, Tobi\u00e1s B, K\u00f3sa JP, et al. Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer. J Endocrinol Invest. 2015;38:313\u201321. https:\/\/doi.org\/10.1007\/s40618-014-0165-7.","journal-title":"J Endocrinol Invest"},{"key":"4483_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.21037\/atm-22-10","volume":"10","author":"J Kuang","year":"2022","unstructured":"Kuang J, Jin Z, Chen L, et al. Serum 25-hydroxyvitamin D level is unreliable as a risk factor and prognostic marker in papillary thyroid cancer. Ann Transl Med. 2022;10:193. https:\/\/doi.org\/10.21037\/atm-22-10.","journal-title":"Ann Transl Med"},{"key":"4483_CR33","doi-asserted-by":"publisher","first-page":"e230373","DOI":"10.1530\/EC-23-0373","volume":"13","author":"Y Shao","year":"2023","unstructured":"Shao Y, Hu X, Wang Y, et al. Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer. Endocr Connect. 2023;13:e230373. https:\/\/doi.org\/10.1530\/EC-23-0373.","journal-title":"Endocr Connect"},{"key":"4483_CR34","doi-asserted-by":"publisher","first-page":"1423305","DOI":"10.3389\/fnut.2024.1423305","volume":"11","author":"Y Hu","year":"2024","unstructured":"Hu Y, Xue C, Ren S, et al. Association between vitamin D status and thyroid cancer: a meta-analysis. Front Nutr. 2024;11:1423305. https:\/\/doi.org\/10.3389\/fnut.2024.1423305.","journal-title":"Front Nutr"},{"key":"4483_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"key":"4483_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12957-021-02247-w","volume":"19","author":"X Li","year":"2021","unstructured":"Li X, Zhang H, Zhou Y, Cheng R. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study. World J Surg Oncol. 2021;19:138. https:\/\/doi.org\/10.1186\/s12957-021-02247-w.","journal-title":"World J Surg Oncol"},{"key":"4483_CR37","doi-asserted-by":"publisher","first-page":"1395900","DOI":"10.3389\/fendo.2024.1395900","volume":"15","author":"Y Huang","year":"2024","unstructured":"Huang Y, Lou P, Li H, et al. Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up. Front Endocrinol (Lausanne). 2024;15:1395900. https:\/\/doi.org\/10.3389\/fendo.2024.1395900.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4483_CR38","doi-asserted-by":"publisher","first-page":"1273498","DOI":"10.3389\/fendo.2023.1273498","volume":"14","author":"L Janicki","year":"2023","unstructured":"Janicki L, Patel A, Jendrzejewski J, Hellmann A. Prevalence and impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto\u2019s thyroiditis: a systematic review with meta-analysis. Front Endocrinol (Lausanne). 2023;14:1273498. https:\/\/doi.org\/10.3389\/fendo.2023.1273498.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4483_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40265-023-01875-8","volume":"83","author":"E Rebelos","year":"2023","unstructured":"Rebelos E, Tentolouris N, Jude E. The role of vitamin D in health and disease: A narrative review on the mechanisms linking vitamin D with disease and the effects of supplementation. Drugs. 2023;83:665\u201385. https:\/\/doi.org\/10.1007\/s40265-023-01875-8.","journal-title":"Drugs"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04483-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:38Z","timestamp":1790634878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04483-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04483-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (Approval No. 2025b0074), which waived the requirement for written informed consent. All data were retrospectively collected from routine clinical care; no additional blood draws or tests were performed for this study. Only anonymized retrospective data were analyzed, with no direct interventions or additional procedures performed on the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"383"}}